{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:33:34Z","timestamp":1777894414471,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ijpharm.2011.07.046","type":"journal-article","created":{"date-parts":[[2011,8,14]],"date-time":"2011-08-14T12:05:02Z","timestamp":1313323502000},"page":"192-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model"],"prefix":"10.1016","volume":"419","author":[{"given":"M.","family":"Vardakou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.A.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.J.","family":"Wickham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Faulks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.07.046_bib0005","unstructured":"British Pharmacopoeia, 2008. Appendix I A."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0010","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1023\/A:1011973909815","article-title":"The effect of cross-linking on the in vivo disintegration of hard gelatin capsules","volume":"15","author":"Brown","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0015","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/jps.2600650941","article-title":"Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy","volume":"65","author":"Casey","year":"1976","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0020","series-title":"Food and Drug Administration","article-title":"Food-effect bioavailability and fed bioequivalence studies","author":"Center for Drug Evaluation and Research (CDER), 2002","year":"2002"},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1023\/B:PHAM.0000026430.73789.e6","article-title":"In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules","volume":"21","author":"Cole","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-011-0386-9","article-title":"Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules","volume":"28","author":"Curatolo","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1023\/A:1007568900147","article-title":"Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture","volume":"17","author":"Digenis","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijpharm.2007.08.045","article-title":"A mini review of scientific and pharmacopeial requirements for the disintegration test","volume":"345","author":"Donauer","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0050","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/00365520410005009","article-title":"Effect of ethanol and some alcoholic beverages on gastric emptying in humans","volume":"39","author":"Franke","year":"2004","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0055","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/jps.20962","article-title":"Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble\/highly permeable drug (efavirenz)","volume":"96","author":"Gao","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0060","series-title":"Units of Measurement, Body Fluids, Composition of the Body, Nutrition","author":"Geigy Scientific Tables","year":"1981"},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0168-3659(03)00011-7","article-title":"Preparation and evaluation of a melt pelletised paracetamol\/stearic acid sustained release delivery system","volume":"88","author":"Grassi","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2008.01.014","article-title":"In vitro methods can forecast the effects of intragastric residence on dosage form performance","volume":"33","author":"Kalantzi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0075","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1023\/A:1026155822121","article-title":"Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using \u03b3 scintigraphy","volume":"20","author":"Kelly","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/j100721a006","article-title":"Viscosity of water at various temperatures","volume":"73","author":"Korson","year":"1969","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1017\/S0007114508039986","article-title":"Effect of intragastric acid stability of fat emulsions on gastric emptying, plasma lipid profile and postprandial satiety","volume":"101","author":"Marciani","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0090","first-page":"G1227","article-title":"Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI","volume":"280","author":"Marciani","year":"2001","journal-title":"Am. J. Physiol.: Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0095","first-page":"G1607","article-title":"Enhancement of intragastric acid stability of a fat emulsion meal delays gastric emptying and increases cholecystokinin release and gallbladder contraction","volume":"292","author":"Marciani","year":"2007","journal-title":"Am. J. Physiol.: Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0145","series-title":"The Composition of Foods","isbn-type":"print","author":"McCance","year":"1991","ISBN":"https:\/\/id.crossref.org\/isbn\/0851863914"},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-011-0387-8","article-title":"The effect of composition and gastric conditions on the self-emulsification process of ibuprofen-loaded self-emulsifying drug delivery systems: a microscopic and dynamic gastric model study","volume":"28","author":"Mercuri","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0378-5173(96)04602-9","article-title":"Indirect gastrointestinal transit monitoring and absorption of theophylline","volume":"139","author":"Peh","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0115","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.fm.2010.07.019","article-title":"Survival of Lactobacillus rhamnosus strains in the upper gastrointestinal tract","volume":"27","author":"Pitino","year":"2010","journal-title":"Food Microbiol."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejps.2004.11.005","article-title":"Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug","volume":"24","author":"Sunesen","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0125","unstructured":"The United States Pharmacopeial Convention, 2008. <701> Disintegration, United States Pharmacopeia."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejps.2006.11.008","article-title":"A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules","volume":"30","author":"Tuleu","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-011-9616-z","article-title":"Achieving antral grinding forces in biorelevant in vitro models: comparing the USP dissolution apparatus II and the dynamic gastric model with human in vivo data","volume":"12","author":"Vardakou","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2011.07.046_bib0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311007630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311007630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:28:08Z","timestamp":1759915688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311007630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0378517311007630"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.07.046","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.07.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}